Clearside Biomedical IPO Info
Company Name: Clearside Biomedical
Stock Symbol: CLSD
Exchange: NASDAQ
Status: Priced
IPO Date: 6/2/2016
IPO Price:
7.00 (
27.71%)
Underwriters
Cowen and Company and Stifel
Amount of Offering: N/A
Number of Shares Offered: 7.2 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Clearside Biomedical, Inc., headquartered in Alpharetta, GA, is a late-stage clinical biopharmaceutical company developing innovative first-in-class drug therapies to treat blinding diseases of the eye using Clearside’s proprietary suprachoroidal space (SCS™) microinjector to reach diseased tissue through the suprachoroidal space. Clearside holds intellectual property protecting the delivery of drugs of any type through the suprachoroidal space to reach the back of the eye.
News Headlines
